Lenzing Shareholders Weigh Their Options as €300 Million Cash Call Nears Launch

Lenzing opens its €300 million rights issue on 6 October at €8.65 per share, as Berenberg downgrades the stock to Hold and cuts its target to €17.

Lenzing has entered the final stretch before a sweeping recapitalisation that will reshape both its shareholder base and its balance sheet, and the market is showing little appetite for the wait. The Austrian fibre producer's stock slipped 1.6% in today's session to €13.80, leaving it hovering just above its 52-week low of €13.14.

At the heart of the restructuring is a fully underwritten rights issue designed to shore up the company's finances. Lenzing plans to issue 34,756,362 new shares at a subscription price of €8.65 apiece, targeting gross proceeds of roughly €300 million. Existing holders will be offered the new stock on a 10-for-9 basis.

The company has lined up firm backing from its anchor investors. The B&C Group and Suzano have jointly committed to subscribing for 18,159,291 of the new shares, while Oberbank has also pledged to exercise all of its own subscription rights. Together, those undertakings guarantee the cash call in full.

A Tight Window for Investors

Shareholders have a narrow window in which to act. The subscription period is set to open on Tuesday, 6 October, and will run through 20 October. Trading in the subscription rights themselves begins on 6 October and closes on 14 October, giving investors a compressed timeframe to decide whether to maintain their stake or sell their entitlements. Any new shares left unsubscribed after the deadline are to be placed through an international private placement to ensure the full issue is completed.

The formal terms were locked in with the publication of the official subscription offer, closing the legal framework around the transaction.

Berenberg Steps Back

Analysts have been quick to recalibrate. On Friday, Berenberg's Sebastian Bray downgraded the stock from "Buy" to "Hold" and slashed his price target from €29.50 to €17.00 — a cut of nearly half.

Bray's more cautious stance rests on two concerns. He expects the earnings boost from higher viscose and cotton prices to come in weaker than previously assumed, and he flagged uncertainty over how committed Brazilian major shareholder Suzano will remain as the financing steps unfold. The drag from the capital measure itself also weighed on his reassessment.

Operational Picture in Focus

Beyond the balance-sheet manoeuvring, attention is turning to Lenzing's underlying performance. The company has pencilled in 5 November for the release of its third-quarter 2026 interim report, which will offer the first detailed read on how the broader market environment is feeding through to its results.

Until then, the smooth execution of the capital increase is likely to be the dominant force shaping sentiment around the stock. With the shares trading barely above their yearly trough, the coming weeks will test whether the guaranteed equity injection is enough to steady investor confidence — or whether the operational headwinds prove the more persistent story.